Cargando…

Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma

Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation with percutaneous hepatic perfusion (PHP) delivers chemotherapy in high doses directly to the liver and is a potentially ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teal, Lindsey, Yorio, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024064/ https://www.ncbi.nlm.nih.gov/pubmed/33859852 http://dx.doi.org/10.1155/2021/8870334

Ejemplares similares

Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma
por: Modi, Sachin, et al.
Publicado: (2022)

Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience
por: Artzner, Christoph, et al.
Publicado: (2019)

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma
por: Schönfeld, Leon, et al.
Publicado: (2020)

Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review
por: Vogel, Arndt, et al.
Publicado: (2016)

Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative Study
por: Kolb, Manuel, et al.
Publicado: (2023)

Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department
por: Öcal, Osman, et al.
Publicado: (2021)

New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
por: Dewald, Cornelia L. A., et al.
Publicado: (2022)

Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience
por: Dewald, Cornelia L. A., et al.
Publicado: (2021)

Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden
por: Brüning, R., et al.
Publicado: (2020)

Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery
por: Dewald, C. L. A., et al.
Publicado: (2020)

Fulminant hepatic failure due to metastatic choroidal melanoma
por: Escobar-Valdivia, Emmanuel, et al.
Publicado: (2017)

Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases
por: Bethlehem, Martijn S., et al.
Publicado: (2021)

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial
por: Tong, T. M. L., et al.
Publicado: (2022)

Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease
por: Karydis, Ioannis, et al.
Publicado: (2017)

Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan
por: Struck, Manuel Florian, et al.
Publicado: (2023)

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
por: Minor, David R., et al.
Publicado: (2022)

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
por: Aedo-Lopez, Veronica, et al.
Publicado: (2022)

Radial Artery Access for Hepatic Chemosaturation: The First Description of Technical Feasibility
por: Frost, Joshua P, et al.
Publicado: (2021)

Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
por: Najjar, Yana G, et al.
Publicado: (2020)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
por: Kraehenbuehl, Lukas, et al.
Publicado: (2022)

Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab
por: Chokr, Nora, et al.
Publicado: (2018)

Synergic Interactions Between Hepatic Stellate Cells and Uveal Melanoma in Metastatic Growth
por: Piquet, Léo, et al.
Publicado: (2019)

Analysis of patient’s X-ray exposure in hepatic chemosaturation procedures: a single center experience
por: Ebel, Sebastian, et al.
Publicado: (2022)

Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
Publicado: (2020)

Fulminant Hepatic Failure Secondary to Primary Hepatic Angiosarcoma
por: Abegunde, Ayokunle T., et al.
Publicado: (2015)

Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
por: Tong, T. M. L., et al.
Publicado: (2022)

Neurological Management of Fulminant Hepatic Failure
por: Frontera, Jennifer A., et al.
Publicado: (2010)

Fulminant hepatic failure: An unusual suspect
por: Layios, Nathalie, et al.
Publicado: (2023)

Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
por: Broman, Kristy K, et al.
Publicado: (2019)

Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
por: Rossi, Ernesto, et al.
Publicado: (2023)

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
por: Salaün, Hélène, et al.
Publicado: (2022)

Fulminant hepatic failure (FHF) due to acute hepatitis C
por: Younis, Bilal Bin, et al.
Publicado: (2015)

Fulminant hepatic failure after repeated exposure to isoflurane
por: Kusuma, Halemani R, et al.
Publicado: (2011)

Improving therapy in metastatic uveal melanoma by understanding prior failures
por: Olson, Daniel J., et al.
Publicado: (2020)

Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab
por: Khimani, Karima, et al.
Publicado: (2022)

Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report
por: Reiter, Selina, et al.
Publicado: (2023)

Fulminant hepatitis
por: Sinclair, Stephen, et al.
Publicado: (1990)

Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
por: Sajan, Abin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qddec96kdr0n8dhfedpi8p4047